Search results
Results from the WOW.Com Content Network
In 1864, the first steam-driven nebulizer was invented in Germany. This inhaler, known as "Siegle's steam spray inhaler", used the Venturi principle to atomize liquid medication, and this was the very beginning of nebulizer therapy. The importance of droplet size was not yet understood, so the efficacy of this first device was unfortunately ...
1971: The journal Inhalation Therapy is renamed to Respiratory Care. 1974: The two US credentialing programs merge into a single credentialing organization called the National Board for Respiratory Therapy (NBRT) in 1974. 1980: President Jimmy Carter proclaimed the first Cystic Fibrosis Awareness Week. (July 22)
An inhaler (puffer, asthma pump or allergy spray) is a medical device used for delivering medicines into the lungs through the work of a person's breathing. This allows medicines to be delivered to and absorbed in the lungs, which provides the ability for targeted medical treatment to this specific region of the body, as well as a reduction in the side effects of oral medications.
Thomas Midgley Jr. (May 18, 1889 – November 2, 1944) was an American mechanical and chemical engineer.He played a major role in developing leaded gasoline (tetraethyl lead) and some of the first chlorofluorocarbons (CFCs), better known in the United States by the brand name Freon; both products were later banned from common use due to their harmful impact on human health and the environment.
A New York doctor was on a flight back home from Spain when crew members announced mid-flight they needed a physician. A 2-year-old boy with asthma didn't have his medicine because his parents ...
The first nebulizer was invented and designed by Sales-Girons in 1858. The first dry powder inhaler was invented by Newton in 1864. And finaly the pressurized Metered Dose Inhaler (pMDI) only was launched in March 1956 as the last type of inhaler. For the treatment of asthma all the 6 type of inhalers have historicaly been used (at least to ...
Learning to breathe again outside the iron lung was often a difficult and frightening process for patients. Most gradually built up strength in their chest muscles through therapy, allowing them to spend increasing amounts of time outside the device. Some patients were able to fully recover and end the treatment.
Pulmonary drug delivery is mainly utilized for topical applications in the lungs, such as the use of inhaled beta-agonists, corticosteroids and anticholinergic agents for the treatment of asthma and COPD, the use of inhaled mucolytics and antibiotics for the treatment of cystic fibrosis (CT) and respiratory viral infections, [1] and the use of inhaled prostacyclin analogs for the treatment of ...